Have a feature idea you'd love to see implemented?
Let us know!
PMVP PMV Pharmaceuticals Inc
Price (delayed)
$1.66
Market cap
$85.52M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.97
Enterprise value
$49.16M
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers.
Highlights
The EPS is up by 40% year-on-year and by 27% since the previous quarter
The company's net income rose by 34% YoY and by 25% QoQ
Key stats
What are the main financial stats of PMVP
Market
Valuations
Earnings
Shares outstanding
51.52M
Market cap
$85.52M
Enterprise value
$49.16M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.4
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$65.05M
EBITDA
-$63.97M
Free cash flow
-$46.37M
Per share
Balance sheet
Liquidity
EPS
-$0.97
Free cash flow per share
-$0.9
Book value per share
$4.17
Revenue per share
$0
TBVPS
$4.61
Total assets
$237.54M
Total liabilities
$23.22M
Debt
$12.99M
Equity
$214.32M
Working capital
$207.4M
Debt to equity
0.06
Current ratio
19.22
Quick ratio
18.77
Net debt/EBITDA
0.57
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-19.8%
Return on equity
-22%
Return on invested capital
-32.4%
Return on capital employed
-28.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PMVP stock price
How has the PMV Pharmaceuticals stock price performed over time
Intraday
3.75%
1 week
3.75%
1 month
11.41%
1 year
29.69%
YTD
-46.45%
QTD
11.41%
Financial performance
How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$76.92M
Net income
-$48.88M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 34% YoY and by 25% QoQ
PMVP's operating income is up by 6% YoY
Growth
What is PMV Pharmaceuticals's growth rate over time
Valuation
What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 40% year-on-year and by 27% since the previous quarter
PMVP's price to book (P/B) is 85% less than its 5-year quarterly average of 2.7 and 43% less than its last 4 quarters average of 0.7
Efficiency
How efficient is PMV Pharmaceuticals business performance
PMV Pharmaceuticals's ROIC has increased by 30% YoY and by 2.1% from the previous quarter
The return on assets has increased by 30% year-on-year and by 24% since the previous quarter
The company's return on equity rose by 29% YoY and by 24% QoQ
Dividends
What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PMVP.
Financial health
How did PMV Pharmaceuticals financials performed over time
The current ratio has grown by 16% YoY and by 14% from the previous quarter
The quick ratio is up by 14% YoY and by 14% QoQ
The debt is 94% smaller than the equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.